---
title: "Zhejiang Yatai Pharmaceutical Co.,Ltd. (002370.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/002370.SZ.md"
symbol: "002370.SZ"
name: "Zhejiang Yatai Pharmaceutical Co.,Ltd."
industry: "Pharmaceuticals"
datetime: "2026-05-20T00:13:46.611Z"
locales:
  - [en](https://longbridge.com/en/quote/002370.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/002370.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/002370.SZ.md)
---

# Zhejiang Yatai Pharmaceutical Co.,Ltd. (002370.SZ)

## Company Overview

Zhejiang Yatai Pharmaceutical Co., Ltd. researches, produces, sells, and exports pharmaceutical products in China and internationally. The company offers solid dosage, cephalosporin powder injection, and freeze-dried powder injection products. It also provides various antibiotic and non-antibiotic drugs.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | CN Market |
| Website | [www.ytyaoye.com](https://www.ytyaoye.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:08.000Z

**Overall: C (0.49)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 135 / 215 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -10.88% |  |
| Net Profit YoY | 244.91% |  |
| P/B Ratio | 4.24 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 4737916866.07 |  |
| Revenue | 317858945.12 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 9.60% | B |
| Profit Margin | 31.91% | A |
| Gross Margin | 35.55% | C |
| Revenue YoY | -10.88% | E |
| Net Profit YoY | 244.91% | A |
| Total Assets YoY | -14.45% | E |
| Net Assets YoY | 12.01% | B |
| Cash Flow Margin | 14.90% | D |
| OCF YoY | -10.88% | E |
| Turnover | 0.24 | D |
| Gearing Ratio | 9.34% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Zhejiang Yatai Pharmaceutical Co.,Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-10.88%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "244.91%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "4.24",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "4737916866.07",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "317858945.12",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "9.60%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "31.91%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "35.55%",
          "rating": "C"
        },
        {
          "name": "Revenue YoY",
          "value": "-10.88%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "244.91%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "-14.45%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "12.01%",
          "rating": "B"
        },
        {
          "name": "Cash Flow Margin",
          "value": "14.90%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "-10.88%",
          "rating": "E"
        },
        {
          "name": "Turnover",
          "value": "0.24",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "9.34%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 47.45 | 100/215 | 96.77 | 41.68 | 38.03 |
| PB | 4.31 | 174/215 | 5.07 | 4.68 | 3.74 |
| PS (TTM) | 15.14 | 202/215 | 16.96 | 15.52 | 12.61 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Allist (688578.SH) | A | A | B | A | B | A |
| 02 | Xingqi Pharmaceutical (300573.SZ) | A | A | A | A | B | A |
| 03 | Hengrui Pharma (600276.SH) | A | B | C | A | B | B |
| 04 | Yunnan Baiyao (000538.SZ) | B | C | B | B | C | B |
| 05 | Haisco (002653.SZ) | A | A | B | B | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/002370.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/002370.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/002370.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/002370.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**